Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC
NCT03573947
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
DRUG:
Nivolumab
DRUG:
Ipilimumab
DRUG:
Paclitaxel
Sponsor
Jeffrey Clarke